BIOMAT Database Logo BIOMAT Database Logo

Effect of cigarette smoking on plasma fibrin clot permeability and susceptibility to lysis. 2009

Anetta Undas, and Roman Topór-Madry, and Wieslawa Tracz, and Mieczyslaw Pasowicz

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012907 Smoking Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand. Smoking Behaviors,Smoking Habit,Behavior, Smoking,Behaviors, Smoking,Habit, Smoking,Habits, Smoking,Smoking Behavior,Smoking Habits
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Anetta Undas, and Roman Topór-Madry, and Wieslawa Tracz, and Mieczyslaw Pasowicz
Plasma fibrin clot proteomics in healthy subjects: Relation to clot permeability and lysis time.
September 2019, Journal of proteomics,
Anetta Undas, and Roman Topór-Madry, and Wieslawa Tracz, and Mieczyslaw Pasowicz
Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis.
May 2006, Journal of thrombosis and haemostasis : JTH,
Anetta Undas, and Roman Topór-Madry, and Wieslawa Tracz, and Mieczyslaw Pasowicz
Reduced plasma fibrin clot permeability and susceptibility to lysis are associated with increased risk of postthrombotic syndrome.
April 2016, Journal of thrombosis and haemostasis : JTH,
Anetta Undas, and Roman Topór-Madry, and Wieslawa Tracz, and Mieczyslaw Pasowicz
Beneficial effect of cigarette smoking cessation on fibrin clot properties.
August 2011, Journal of thrombosis and thrombolysis,
Anetta Undas, and Roman Topór-Madry, and Wieslawa Tracz, and Mieczyslaw Pasowicz
Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
June 2006, Arteriosclerosis, thrombosis, and vascular biology,
Anetta Undas, and Roman Topór-Madry, and Wieslawa Tracz, and Mieczyslaw Pasowicz
Reduced plasma fibrin clot permeability and susceptibility to lysis in patients with inflammatory bowel disease: a novel prothrombotic mechanism.
November 2013, Inflammatory bowel diseases,
Anetta Undas, and Roman Topór-Madry, and Wieslawa Tracz, and Mieczyslaw Pasowicz
Fibrin Clot Formation and Lysis in Plasma.
September 2020, Methods and protocols,
Anetta Undas, and Roman Topór-Madry, and Wieslawa Tracz, and Mieczyslaw Pasowicz
Kinetics of fibrin clot lysis.
January 1968, The Biochemical journal,
Anetta Undas, and Roman Topór-Madry, and Wieslawa Tracz, and Mieczyslaw Pasowicz
Urokinase-induced fibrin clot lysis and its inhibition by plasma.
January 1980, Upsala journal of medical sciences,
Anetta Undas, and Roman Topór-Madry, and Wieslawa Tracz, and Mieczyslaw Pasowicz
Effect of oxidation-modified fibrinogen on the formation and lysis of fibrin clot in the plasma.
December 2009, Bulletin of experimental biology and medicine,
Copied contents to your clipboard!